We are live on ! Find out more
MNA

Manning & Napier Advisors Portfolio holdings

AUM $7.8B
1-Year Est. Return 25.03%
This Fund
S&P 500
This Quarter Est. Return
+15.96%
1 Year Est. Return
+25.03%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.8B
AUM Growth
+$707M
Cap. Flow
-$136M
Cap. Flow %
-1.74%
Top 10 Hldgs %
31.71%
Holding
885
New
270
Increased
236
Reduced
238
Closed
21

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$96.8M
2
TRU icon
TransUnion
TRU
+$88M
3
CDNS icon
Cadence Design Systems
CDNS
+$71.2M
4
SBS icon
Sabesp
SBS
+$70.6M
5
NVDA icon
NVIDIA
NVDA
+$65.9M

Sector Composition

Rank Sector Weight
1 Technology 23.49%
2 Miscellaneous 18.14%
3 Financials 13.71%
4 Healthcare 12.57%
5 Consumer Discretionary 9.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYK icon
876
Stryker
SYK
$118B
-22
Closed -$7.17K
TAP icon
877
Molson Coors Class B
TAP
$7.56B
-2,347
Closed -$101K
UGI icon
878
UGI
UGI
$8.11B
-55,348
Closed -$2.02M
VCR icon
879
Vanguard Consumer Discretionary ETF
VCR
$6B
-9
Closed -$3.23K
WAT icon
880
Waters Corp
WAT
$40.6B
-38
Closed -$11.3K
YUMC icon
881
Yum China
YUMC
$14.9B
-36,186
Closed -$1.77M
VG
882
Venture Global Inc
VG
$36.2B
-988
Closed -$15.6K

Similar funds

Manning & Napier Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Manning & Napier Advisors held 885 positions worth $7.8B, up 10% from $7.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Manning & Napier Advisors's Q2 2026 filing shows 270 new, 236 increased, 238 reduced and 21 closed positions. Its largest new stake was Tenet Healthcare: 901,645 shares worth $169M. The largest sale was Vertex Pharmaceuticals, an estimated $96.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Miscellaneous and Financials.

  • Manning & Napier Advisors's largest Q2 2026 buy was Tenet Healthcare: 901,645 shares worth $169M.
  • Manning & Napier Advisors added most to Vanguard Intermediate-Term Treasury ETF in Q2 2026, an estimated $157M increase.
  • Manning & Napier Advisors's biggest Q2 2026 reduction was Vertex Pharmaceuticals, cutting an estimated $96.8M.
  • Manning & Napier Advisors fully exited Plains All American Pipeline in Q2 2026, selling an estimated $4.47M.
  • Manning & Napier Advisors's ten largest holdings make up 32% of its $7.8B portfolio in Q2 2026.
  • Manning & Napier Advisors opened 270 new positions and closed 21 in Q2 2026.
  • Manning & Napier Advisors's portfolio value rose 10% quarter-over-quarter to $7.8B.

Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.